Tse G M K, Tan P-H, Lui P C W, Gilks C B, Poon C S P, Ma T K F, Law B K B, Lam W W M
Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong SAR, China.
J Clin Pathol. 2007 Mar;60(3):315-20. doi: 10.1136/jcp.2006.036830. Epub 2006 May 12.
Histological differentiation of mammary papillary lesions can be difficult. The evaluation of myoepithelial cells can be helpful, with benign papilloma showing a continuous myoepithelial cell layer, which becomes attenuated or absent in malignant papillary lesions.
A large series of 100 papillomas (28 papillomas with florid epithelial hyperplasia) and 68 papillary carcinomas (9 invasive, 44 in situ, and 15 ductal carcinomas in situ (DCIS) involving papillomas) of the breast were stained for myoepithelial cells by immunohistochemistry using antibodies to smooth-muscle actin (SMA), p63, CD10 and cytokeratin (CK) 14.
In the papillomas, using these four antibodies, myoepithelial cells were positive in 88%, 99%, 91% and 95% of cases, respectively, with SMA showing marked stromal component cell staining and CD10 showing epithelial and stromal staining. CK14 also showed epithelial staining in 71% of papillomas and 96% of papillomas with florid epithelial hyperplasia. In the papillary carcinomas, 36 (53%) cases showed staining of myoepithelial cells that were scattered, discontinuous and diminished in number and the remaining 32 (47%) cases did not show myoepithelial cells. Invasive papillary carcinoma has the lowest proportion (33%) with myoepithelial cells, and DCIS involving papillomas had the highest proportion (87%).
p63 had the highest sensitivity and did not cross-react with stromal cells and only rarely with epithelial cells. CK14 has the added ability to distinguish between florid epithelial hyperplasia involving papilloma and DCIS involving papillomas. CK14 and p63 may be used as an adjunct in assessing difficult papillary lesions of the breast.
乳腺乳头状病变的组织学鉴别可能具有挑战性。肌上皮细胞的评估可能会有所帮助,良性乳头状瘤显示有连续的肌上皮细胞层,而恶性乳头状病变中的肌上皮细胞层会变薄或消失。
采用免疫组织化学方法,使用抗平滑肌肌动蛋白(SMA)、p63、CD10和细胞角蛋白(CK)14的抗体,对100例乳头状瘤(28例伴有旺炽性上皮增生的乳头状瘤)和68例乳腺乳头状癌(9例浸润性、44例原位癌以及15例累及乳头状瘤的导管原位癌(DCIS))进行肌上皮细胞染色。
在乳头状瘤中,使用这四种抗体,肌上皮细胞阳性率分别为88%、99%、91%和95%,SMA显示明显的间质成分细胞染色,CD10显示上皮和间质染色。CK14在71%的乳头状瘤以及96%伴有旺炽性上皮增生的乳头状瘤中也显示上皮染色。在乳头状癌中,36例(53%)显示肌上皮细胞染色,呈散在、不连续且数量减少,其余32例(47%)未显示肌上皮细胞。浸润性乳头状癌中肌上皮细胞比例最低(33%),累及乳头状瘤的DCIS比例最高(87%)。
p63具有最高的敏感性,且不与间质细胞交叉反应,仅偶尔与上皮细胞交叉反应。CK14具有额外的能力来区分累及乳头状瘤的旺炽性上皮增生和累及乳头状瘤的DCIS。CK14和p63可作为评估乳腺疑难乳头状病变的辅助手段。